Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

PYXS

Pyxis Oncology (PYXS)

Pyxis Oncology Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PYXS
DateHeureSourceTitreSymboleSociété
04/02/202521h45Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PYXSPyxis Oncology Inc
04/02/202513h40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PYXSPyxis Oncology Inc
04/02/202513h30GlobeNewswire Inc.Pyxis Oncology Initiates New PYX-201 Combination Trial and Initiates Cohort Expansions of Ongoing Monotherapy TrialNASDAQ:PYXSPyxis Oncology Inc
23/12/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
19/12/202422h08GlobeNewswire Inc.Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201NASDAQ:PYXSPyxis Oncology Inc
20/11/202422h05GlobeNewswire Inc.Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 DataNASDAQ:PYXSPyxis Oncology Inc
12/11/202422h37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PYXSPyxis Oncology Inc
12/11/202413h30GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024NASDAQ:PYXSPyxis Oncology Inc
11/11/202413h00GlobeNewswire Inc.Pyxis Oncology to Host In-Person (NYC) and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201NASDAQ:PYXSPyxis Oncology Inc
06/11/202422h36Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PYXSPyxis Oncology Inc
25/09/202422h08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PYXSPyxis Oncology Inc
13/09/202422h26Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PYXSPyxis Oncology Inc
29/08/202413h30GlobeNewswire Inc.Pyxis Oncology to Participate in Two Upcoming Investor ConferencesNASDAQ:PYXSPyxis Oncology Inc
14/08/202422h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PYXSPyxis Oncology Inc
14/08/202422h05GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024NASDAQ:PYXSPyxis Oncology Inc
29/07/202414h00GlobeNewswire Inc.Pyxis Oncology to Participate in the BTIG Virtual Biotechnology ConferenceNASDAQ:PYXSPyxis Oncology Inc
28/06/202422h30GlobeNewswire Inc.Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PYXSPyxis Oncology Inc
10/06/202413h30GlobeNewswire Inc.Pyxis Oncology Expands Board of Directors with Appointment of Michael A. MetzgerNASDAQ:PYXSPyxis Oncology Inc
30/05/202413h30GlobeNewswire Inc.Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare ConferenceNASDAQ:PYXSPyxis Oncology Inc
14/05/202413h30GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024NASDAQ:PYXSPyxis Oncology Inc
09/05/202413h30GlobeNewswire Inc.Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare ConferenceNASDAQ:PYXSPyxis Oncology Inc
27/03/202412h30GlobeNewswire Inc.Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty RightsNASDAQ:PYXSPyxis Oncology Inc
21/03/202412h30GlobeNewswire Inc.Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023NASDAQ:PYXSPyxis Oncology Inc
13/03/202413h00GlobeNewswire Inc.Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFANASDAQ:PYXSPyxis Oncology Inc
08/03/202422h03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYXSPyxis Oncology Inc
07/03/202422h30GlobeNewswire Inc.Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024NASDAQ:PYXSPyxis Oncology Inc
05/03/202422h45GlobeNewswire Inc.Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual MeetingNASDAQ:PYXSPyxis Oncology Inc
27/02/202414h00GlobeNewswire Inc.Pyxis Oncology Announces $50 Million Private PlacementNASDAQ:PYXSPyxis Oncology Inc
06/12/202322h50Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PYXSPyxis Oncology Inc
28/11/202313h00GlobeNewswire Inc.Pyxis Oncology Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical OfficerNASDAQ:PYXSPyxis Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:PYXS